Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Biocatalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114703169A reveals a novel L-threonine aldolase mutant for Droxidopa. Achieves 92.89% selectivity. Ideal for pharma intermediates supply.
Patent CN106701723B details FSAA mutants for chiral synthesis. Offers cost reduction in chiral building block manufacturing with high stereoselectivity.
Patent CN112553285B reveals a novel omega-transaminase method for L-glufosinate-ammonium. Achieve high purity and cost reduction in agrochemical manufacturing with scalable biocatalysis.
Patent CN105316250A reveals Empedobacter brevis strain for high-purity chiral alcohols. Offers cost reduction and scalable supply for pharmaceutical intermediates.
Patent CN113005162A reveals a novel enzymatic route for NMN. Discover cost-effective, scalable production methods for high-purity nutritional ingredients.
Discover the breakthrough recombinant dehydrogenase technology for L-glufosinate-ammonium production. Enhance supply chain reliability and reduce manufacturing costs with high-purity agrochemical intermediates.
Patent CN116064449A discloses stable transaminase mutants for bulky chiral amines. Enables green synthesis, cost reduction, and reliable supply for pharmaceutical intermediates.
Patent CN113088501A reveals a novel glutamate dehydrogenase mutant for L-glufosinate-ammonium production. Achieve ≥99% conversion and optical purity with reduced coenzyme costs.
Patent CN105567652A reveals high-purity (R)-HPBE synthesis via novel ketoreductase, offering significant cost reduction and supply chain reliability for ACE inhibitor manufacturing.
Patent CN111057725B reveals enzymatic synthesis for high-purity fungicide intermediates. Discover cost reduction and scalable supply chain solutions for Florylpicoxamid production.
Patent CN110628739B reveals high-efficiency enzymatic synthesis for chiral amines. Achieve >99% ee and reduced costs with scalable biocatalytic solutions.
Patent CN112941043B details a carbonyl reductase mutant for synthesizing chiral intermediates. Offers high yield and scalability for carbapenem antibiotic production supply chains.
Patent CN102965403A reveals a novel recombinant ketoreductase method for statin side chains, offering superior purity and simplified downstream processing for pharmaceutical manufacturers.
Patent CN102465157B details enzymatic synthesis of pregabalin intermediate offering high purity and scalable supply chain solutions for global pharmaceutical manufacturers.
Patent CN107828831B details a green enzymatic route for chiral tetrahydrofuran acids, offering cost reduction and high purity for pharmaceutical intermediate manufacturing.
Patent CN104313064A details a high-yield biocatalytic route for chiral esters. Discover cost-effective, scalable manufacturing for pharmaceutical intermediates.
Patent CN113293152B details short-chain dehydrogenase mutants for asymmetric reduction. This report analyzes cost reduction in chiral alcohol manufacturing and supply chain reliability for global buyers.
Patent CN108642119B details a lipase-catalyzed method for high-purity chiral intermediates, offering cost-effective and scalable manufacturing solutions.
Patent CN110964703B reveals high-efficiency ketoreductase for duloxetine intermediate. Achieve cost reduction and supply reliability in pharmaceutical manufacturing.
Patent CN107022587A details a novel enzymatic route for Ezetimibe intermediates using tubular reactors. Discover cost reduction in API manufacturing and high-purity supply solutions.